Early Histologic Improvement Demonstrated with Oral Ozanimod in Patients with Moderately to Severely Active Crohn's Disease in the STEPSTONE Trial

Brian G. Feagan  1     Geert R. D'Haens  2     Keith Usiskin  3     W Jerry Liu  3     Rish K. Pai  4    
1 Robarts Clinical Trials Inc.,London,Canada
2 AMC Amsterdam Inflammatory Bowel Disease Centre - Academic Medical Center, AMC Amsterdam Inflammator,Amsterdam,Netherlands
3 Celgene Corp,Summit,United States
4 Mayo Clinic,Scottsdale,United States

UEG Week 2019

United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019

Login to access library content


Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing